Trademark: 97253726
Word
PRESCIDO
Status
Pending
Status Code
731
Status Date
Friday, November 17, 2023
Serial Number
97253726
Mark Type
4000
Filing Date
Friday, February 4, 2022
Published for Opposition
Tuesday, September 27, 2022

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
10 Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for diagnosing and treating gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for use in hematology and in tissue and organ transplantation; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical apparatus and instruments for use in urology; medical apparatus and instruments for ophthalmological use; medical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical use in the nature of radiological apparatus for medical purposes; genetic testing apparatus and instruments for medical use in the nature of genetic testing apparatus for medical purposes; electromagnetic drug delivery apparatus and instruments for medical use in the nature of electromagnetic drug delivery apparatus for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations in the nature of medical apparatus for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical use in the nature of apparatus for DNA and RNA testing for medical purposes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for introducing pharmaceutical preparations into the human body in the nature of medical apparatus for introducing pharmaceutical preparations into the human body
The wording "PRESCIDO" has no meaning in a foreign language.

Trademark Events
Nov 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 17, 2023
Sou Extension 2 Granted
Nov 17, 2023
Sou Extension 2 Filed
Nov 17, 2023
Sou Teas Extension Received
May 12, 2023
Notice Of Approval Of Extension Request E-Mailed
May 10, 2023
Sou Extension 1 Granted
May 10, 2023
Sou Extension 1 Filed
May 10, 2023
Sou Teas Extension Received
Nov 22, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 27, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2022
Published For Opposition
Sep 7, 2022
Notification Of Notice Of Publication E-Mailed
Aug 18, 2022
Approved For Pub - Principal Register
Aug 17, 2022
Teas/Email Correspondence Entered
Aug 17, 2022
Correspondence Received In Law Office
Aug 17, 2022
Teas Response To Office Action Received
Aug 2, 2022
Notification Of Non-Final Action E-Mailed
Aug 2, 2022
Non-Final Action E-Mailed
Aug 2, 2022
Non-Final Action Written
Aug 2, 2022
Assigned To Examiner
Feb 9, 2022
New Application Office Supplied Data Entered
Feb 8, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24